More General News
View Older Stories View Newer Stories-
Oscar Health stock soars after report of potential Obamacare subsidy extension
-
Novo Nordisk Alzheimer's drug trials fail in blow to weight-loss giant
-
Nvidia chip sales to China among key decisions for Trump, says Lutnick
-
Buy pullback in stocks for more gains in 2026: Morgan Stanley's Wilson
-
Booking upgraded at Bank of America as AI risks are 'overdone'
-
Exclusive: Eleos Life to unveils 24/7 AI voice agent
-
Amazon's data center footprint tops 900, far larger than thought
-
Novo Nordisk shares sink after Alzheimer’s drug trial failure
-
Wall Street's biggest bull: DB sets S&P 500 2026-end target at 8,000
-
Exclusive-U.S. senators call for probe of scam ads on Facebook and Instagram
-
Record US Black Friday crowds to find fewer bargains amid high prices
-
Bill Ackman’s viral dating advice caps wild week on Wall Street
-
Trump admin discussed allowing Nvidia H200 sales to China
-
Bidders for Warner Bros Discovery face barrage of political and regulatory risks
-
Ford reaffirms annual EBIT guidance after latest aluminum supplier fire
-
Ford shares gain after affirming guidance despite supplier fire
-
Tesla Is Sued Over 2023 Fatal Model 3 Crash In Washington State - Bloomberg
-
AECOM, Jacobs downgraded on uncertainty over AI’s LT impact on engineering revenue
-
Exclusive-Glass Lewis mulls US investment adviser registration, could ease criticism
-
UBS says no ’Germany Moment’ for Ottawa as Loonie tracks the Fed
-
US FDA investigates Takeda's blood disorder drug after pediatric death
-
Zelenskiy, after Vance call, says Ukraine will work on peace plan at advisor level
-
El-Erian warns markets not to overreact to Williams’ dovish comments
-
Apple most immune to memory price rises, others more impacted: Bernstein
-
Carvana's scale and vertical integration will widen its lead, says Deutsche Bank
-
Nokia plans $4 billion AI investment in the United States
-
IBM: Oppenheimer initiates coverage with Outperform rating on software-led growth
-
Lilly, Novo Nordisk back direct-to-employer programs to expand access to weight-loss drugs
-
G-20: Protect Critical Minerals Against Unilateral Trade Curbs - Bloomberg
-
Lilly becomes first drugmaker to hit $1 trillion valuation on weight-loss demand
-
Barclays downgrades UPM as fading pulp outlook leaves shares without a catalyst
-
Strategy's Saylor defends business model amid MSCI index concerns
-
RTX JV secures $1.25 billion Iron Dome missile deal with Israel
-
Fed’s Logan: rates should be held steady for a while
-
Bath & Body Works hit with downgrades as weak demand overshadows new strategy
-
Fed’s Collins hesitant on December rate cut
-
Can AI power the market even higher in 2026?
-
AI stock surge won't end like the dot-com boom, says Fed's Jefferson
-
Fed's Jefferson: AI-related stock gains unlikely to be dot-com boom replay
-
Patients in Denmark compensated for vision loss linked to Novo’s Wegovy
-
Seven signs the U.S. is turning against AI, according to Jefferies
-
US equity funds attract fifth straight weekly inflow amid robust earnings results
-
Investors' views on extended markets' selloff
-
Futures climb after Fed’s Williams signals December rate cut
-
Fed's Williams sees room for "near term" rate cuts
-
Raymond James: AI has turned a cyclical sector into a 'secular boom'
-
Williams' comments boost odds of a Fed cut, though policy hawks remain adamant
-
Can the November pullback yield a Santa Claus rally? Here’s a look at seasonals
-
BJ’s Wholesale Club shares rise as earnings top estimates
-
Global coffee prices plunge after Trump removes tariffs on Brazil
